StemCell Institute's total assets for Q3 2024 were ¥7.18B, an increase of 3.53% from the previous quarter. JP:7096 total liabilities were ¥4.50B for the fiscal quarter, a 10.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.